论文部分内容阅读
选取我院2012年6月~2014年6月收治的肝癌患者80例。将所有患者按照随机数字法分为观察组和对照组各40例。对照组采用单纯三维适形放疗法进行治疗,观察组采用三维适形放疗联合参一胶囊进行治疗,对比观察两组患者的临床治疗效果以及不良反应发生率情况。结果观察组患者在治疗后的临床受益有效率达到77.5%(31/40),显著高于对照组62.5%(25/40),差异具有统计学意义(P<0.05)。观察组患者的近期治疗有效率为80.0%(32/40),显著高于对照组患者的57.5%(23/40),差异具有统计学意义(P<0.05)。观察组患者包细胞下降的发生率为35.0%(14/40),对照组发生率为37.5%(15/40),差异无统计学意义(P>0.05)。两组患者在胃肠道不良反应发生率情况的差异没有统计学意义(P>0.05)。采用三维适形放疗联合参一胶囊能够有效提高肝癌患者的临床治疗效果,并且能够不良反应发生率较低,值得临床推广运用。
Select 80 cases of liver cancer patients admitted to our hospital from June 2012 to June 2014. All patients were randomly divided into observation group and control group with 40 cases each. The control group was treated with simple three-dimensional conformal radiotherapy. The observation group was treated with three-dimensional conformal radiotherapy combined with Shenyi Capsule. The clinical treatment effect and incidence of adverse reactions were compared between the two groups. Results The effective rate of clinical benefit in the observation group was 77.5% (31/40) after treatment, which was significantly higher than that of the control group (62.5% (25/40)). The difference was statistically significant (P<0.05). The effective rate of recent treatment in the observation group was 80.0% (32/40), which was significantly higher than that of the control group (57.5% (23/40)). The difference was statistically significant (P<0.05). The incidence of decline in packaged cells was 35.0% (14/40) in the observation group and 37.5% (15/40) in the control group. The difference was not statistically significant (P>0.05). There was no significant difference in the incidence of adverse reactions in the gastrointestinal tract between the two groups (P>0.05). The use of three-dimensional conformal radiotherapy combined with Shenyi capsule can effectively improve the clinical treatment of patients with liver cancer, and can lower the incidence of adverse reactions, it is worthy of clinical application.